• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Antiviral Action of Methylated β-Lactoglobulin on the Human Influenza Virus A Subtype H3N2

tetano

Editor, Senior Moderator
Probiotics Antimicrob Proteins. 2010 Jun;2(2):104-11. doi: 10.1007/s12602-010-9036-5.
[h=1]Antiviral Action of Methylated β-Lactoglobulin on the Human Influenza Virus A Subtype H3N2.[/h] Sitohy M[SUP]1,[/SUP][SUP]2[/SUP], Besse B[SUP]3[/SUP], Billaudel S[SUP]3[/SUP], Haertl? T[SUP]1[/SUP], Chobert JM[SUP]4[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Antiviral activity of methylated β-lactoglobulin (Met-BLG) against H3N2 infected into MDCK cell lines depended on concentration of Met-BLG, viral load, and duration of infection. IC50% of the hemagglutination activity for 1 and 0.2 MOI (multiplicity of infection) after 24 h of incubation at 37 ?C in the presence of 5% CO2 were 20 ? 0.8 and 17 ? 0.7 μg mL(-1) Met-BLG, respectively. Longer incubation period (4 days) was associated with low IC50% of the hemagglutination activity (7.1 ? 0.3 μg mL(-1) Met-BLG) and low IC50% of immuno-fluorescence of viral nucleoproteins (9.7 ? 0.4 μg mL(-1) Met-BLG) when using 0.2 and 0.1 MOI, respectively. A concentration of 25 μg mL(-1) of Met-BLG reduced the amount of replicating virus by about 2 and 1.3 logs when the viral load was 0.01 and 0.1 MOI, respectively, while higher concentrations reduced it by about 5-6 logs. Antiviral action of Met-BLG was coupled with a cellular protective action, which reached 100% when using 0.01 and 0.1 MOI and 83% when using 1.0 MOI. The time of Met-BLG addition after the viral infection was determinant for its antiviral efficacy and for its protection of the infected MDCK cell lines. Anti-hemagglutination action and cell protective action decreased gradually and in parallel with the delay in the time of Met-BLG addition to disappear totally after 10 h delay.


[h=4]KEYWORDS:[/h] Antiviral activity; Beta-lactoglobulin; Esterification; H3N2

PMID: 26781119 [PubMed]
 
Back
Top Bottom